Your browser doesn't support javascript.
loading
Treatment of UTIs in Infants <2 Months: A Living Systematic Review.
Nama, Nassr; Donken, Robine; Pawliuk, Colleen; Leache, Leire; Sadarangani, Manish; Carwana, Matthew.
Afiliación
  • Nama N; Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada nassr.nama@alumni.ubc.ca.
  • Donken R; Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Pawliuk C; Vaccine Evaluation Center.
  • Leache L; Evidence to Innovation, British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Sadarangani M; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Spain.
  • Carwana M; Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
Hosp Pediatr ; 11(9): 1017-1030, 2021 09.
Article en En | MEDLINE | ID: mdl-34446534
ABSTRACT
CONTEXT Urinary tract infections (UTIs) are the most common bacterial infections in infants <2 months of age. However, there are no clear guidelines on the appropriate duration of antibiotics in this age group.

OBJECTIVE:

In this living systematic review, we compared different durations of parenteral antibiotics (≤3 vs >3 days) in neonates and young infants (<2 months) with UTIs. The secondary objective was to compare different durations of total antibiotic courses (≤10 vs >10 days). DATA SOURCES MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Web of Science, Literatura Latino-Americana e do Caribe em Ciências da Saúde, Google Scholar, and gray literature, up to March 2, 2021. STUDY SELECTION Citations were screened in triplicate by using a crowdsourcing methodology, to identify randomized controlled trials and observational studies. DATA EXTRACTION Data were extracted by 2 crowd members and verified by an expert investigator. Outcomes were pooled via random-effects models.

RESULTS:

A total of 10 334 citations were screened, and 12 eligible studies were identified. A total of 59 of 3480 (1.7% [95% confidence interval (CI) 1.3% to 2.2%]) infants had a UTI recurrence within 30 days after short parenteral treatment (≤3 days), and 47 of 1971 (2.4% [95% CI 1.8% to 3.2%]) after longer courses. The pooled adjusted odds ratio for UTI recurrence with a short versus long duration of parenteral antibiotics was 1.02 (95% CI 0.64 to 1.61; P = .95; n = 5451). A total of 5 studies assessed the risk of recurrence on the basis of the total duration of antibiotics (≤10 vs >10 days) with no significant differences (pooled odds ratio 1.29 [95% CI 0.45 to 3.66; P = .63; n = 491).

CONCLUSIONS:

On the basis of retrospective studies and Grading of Recommendations, Assessment, Development, and Evaluation level low evidence, short and long duration of parenteral antibiotics were associated with a similar risk of UTI recurrence in infants <2 months.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Bacterianas / Infecciones Urinarias Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans / Infant / Newborn Idioma: En Revista: Hosp Pediatr Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Bacterianas / Infecciones Urinarias Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans / Infant / Newborn Idioma: En Revista: Hosp Pediatr Año: 2021 Tipo del documento: Article País de afiliación: Canadá